Chemical Reviews, volume 116, issue 2, pages 422-518

Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.

Yu Zhou 1
Jiang Wang 1
Zhanni Gu 1
Shuni Wang 1
Wei Zhu 1
José Luis Aceña 2, 3
Vadim A Soloshonok 2, 4
Kunisuke Izawa 5
Hong Liu 1
Publication typeJournal Article
Publication date2016-01-12
Journal: Chemical Reviews
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor62.1
ISSN00092665, 15206890
General Chemistry
Abstract
Compounds Currently in Phase II−III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas Yu Zhou,† Jiang Wang,† Zhanni Gu,† Shuni Wang,† Wei Zhu,† Jose ́ Luis Aceña,*,‡,§ Vadim A. Soloshonok,*,‡,∥ Kunisuke Izawa,* and Hong Liu*,† †Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China ‡Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizab́al 3, 20018 San Sebastiań, Spain Department of Organic Chemistry, Autońoma University of Madrid, Cantoblanco, 28049 Madrid, Spain IKERBASQUE, Basque Foundation for Science, María Díaz de Haro 3, 48013 Bilbao, Spain Hamari Chemicals Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, Japan 533-0024

Top-30

Citations by journals

20
40
60
80
100
120
140
160
180
Journal of Organic Chemistry
169 publications, 7.9%
Organic Letters
169 publications, 7.9%
Angewandte Chemie - International Edition
107 publications, 5%
Angewandte Chemie
107 publications, 5%
Organic and Biomolecular Chemistry
93 publications, 4.35%
European Journal of Organic Chemistry
91 publications, 4.25%
Advanced Synthesis and Catalysis
91 publications, 4.25%
Journal of Fluorine Chemistry
87 publications, 4.07%
Chemistry - A European Journal
82 publications, 3.83%
Chemical Communications
81 publications, 3.79%
Organic Chemistry Frontiers
77 publications, 3.6%
ACS Catalysis
42 publications, 1.96%
Journal of the American Chemical Society
42 publications, 1.96%
Molecules
39 publications, 1.82%
Asian Journal of Organic Chemistry
36 publications, 1.68%
Tetrahedron Letters
35 publications, 1.64%
Beilstein Journal of Organic Chemistry
31 publications, 1.45%
Chemical Science
31 publications, 1.45%
Synthesis
31 publications, 1.45%
Tetrahedron
26 publications, 1.21%
Chemical Record
21 publications, 0.98%
ChemistrySelect
21 publications, 0.98%
RSC Advances
21 publications, 0.98%
Green Chemistry
18 publications, 0.84%
Chinese Chemical Letters
17 publications, 0.79%
Organic Process Research and Development
16 publications, 0.75%
Journal of Medicinal Chemistry
16 publications, 0.75%
Chinese Journal of Chemistry
15 publications, 0.7%
Synlett
14 publications, 0.65%
20
40
60
80
100
120
140
160
180

Citations by publishers

100
200
300
400
500
600
700
Wiley
657 publications, 30.7%
American Chemical Society (ACS)
530 publications, 24.77%
Royal Society of Chemistry (RSC)
371 publications, 17.34%
Elsevier
279 publications, 13.04%
Springer Nature
68 publications, 3.18%
Multidisciplinary Digital Publishing Institute (MDPI)
61 publications, 2.85%
Thieme
45 publications, 2.1%
Beilstein-Institut
31 publications, 1.45%
Taylor & Francis
15 publications, 0.7%
Pleiades Publishing
14 publications, 0.65%
Bentham Science
8 publications, 0.37%
Shanghai Institute of Organic Chemistry
8 publications, 0.37%
The Chemical Society of Japan
7 publications, 0.33%
Frontiers Media S.A.
5 publications, 0.23%
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
3 publications, 0.14%
American Association for the Advancement of Science (AAAS)
3 publications, 0.14%
Canadian Science Publishing
2 publications, 0.09%
Pharmaceutical Society of Japan
2 publications, 0.09%
Society of Synthetic Organic Chemistry
2 publications, 0.09%
Akademiai Kiado
2 publications, 0.09%
King Saud University
2 publications, 0.09%
Scientific Research Publishing
2 publications, 0.09%
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.05%
CSIRO Publishing
1 publication, 0.05%
The Electrochemical Society of Japan
1 publication, 0.05%
Impact Journals
1 publication, 0.05%
International Union of Crystallography (IUCr)
1 publication, 0.05%
Akademizdatcenter Nauka
1 publication, 0.05%
Public Library of Science (PLoS)
1 publication, 0.05%
100
200
300
400
500
600
700
  • We do not take into account publications without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Zhou Yu. et al. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. // Chemical Reviews. 2016. Vol. 116. No. 2. pp. 422-518.
GOST all authors (up to 50) Copy
Zhou Yu., Wang J., Gu Z., Wang S., Zhu W., Aceña J. L., Soloshonok V. A., Izawa K., Liu H. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. // Chemical Reviews. 2016. Vol. 116. No. 2. pp. 422-518.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.chemrev.5b00392
UR - https://doi.org/10.1021/acs.chemrev.5b00392
TI - Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.
T2 - Chemical Reviews
AU - Gu, Zhanni
AU - Wang, Shuni
AU - Aceña, José Luis
AU - Soloshonok, Vadim A
AU - Zhou, Yu
AU - Wang, Jiang
AU - Zhu, Wei
AU - Izawa, Kunisuke
AU - Liu, Hong
PY - 2016
DA - 2016/01/12 00:00:00
PB - American Chemical Society (ACS)
SP - 422-518
IS - 2
VL - 116
SN - 0009-2665
SN - 1520-6890
ER -
BibTex |
Cite this
BibTex Copy
@article{2016_Zhou,
author = {Zhanni Gu and Shuni Wang and José Luis Aceña and Vadim A Soloshonok and Yu Zhou and Jiang Wang and Wei Zhu and Kunisuke Izawa and Hong Liu},
title = {Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.},
journal = {Chemical Reviews},
year = {2016},
volume = {116},
publisher = {American Chemical Society (ACS)},
month = {jan},
url = {https://doi.org/10.1021/acs.chemrev.5b00392},
number = {2},
pages = {422--518},
doi = {10.1021/acs.chemrev.5b00392}
}
MLA
Cite this
MLA Copy
Zhou, Yu., et al. “Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas..” Chemical Reviews, vol. 116, no. 2, Jan. 2016, pp. 422-518. https://doi.org/10.1021/acs.chemrev.5b00392.
Found error?